Iteos Therapeutics Inc (ITOS) — Defensive Interval Ratio
Iteos Therapeutics Inc (ITOS) has a Defensive Interval Ratio of 1611 days as of June 2025. Defensive assets of $310.16 Million (cash $-, short-term investments $307.61 Million, receivables $2.55 Million) cover 1611 days of daily cash needs of $192.53K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Iteos Therapeutics Inc Defensive Interval Ratio (2018–2024)
This chart shows how Iteos Therapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2018 to 2024. As of June 2025, the ratio stands at 1611 days, meaning defensive assets of $310.16 Million can fund 1611 days of operations without new revenue. For the complete balance sheet picture, see total assets of Iteos Therapeutics Inc.
Annual Defensive Interval Ratio for Iteos Therapeutics Inc (2018–2024)
The table below presents the year-by-year Defensive Interval Ratio for Iteos Therapeutics Inc from 2018 to 2024, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of Iteos Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 3221 days | $356.21 Million | $110.58K/day | $- | $352.52 Million | ▲ +601 days |
| 2023 | 2620 days | $287.24 Million | $109.63K/day | $- | $280.74 Million | ▼ -255 days |
| 2022 | 2875 days | $330.79 Million | $115.07K/day | $- | $328.36 Million | ▲ +2860 days |
| 2021 | 15 days | $12.09 Million | $833.22K/day | $- | $0.00 | ▲ +7 days |
| 2020 | 8 days | $325.00K | $41.09K/day | $- | $- | ▼ -139 days |
| 2019 | 147 days | $5.33 Million | $36.15K/day | $- | $- | ▲ +63 days |
| 2018 | 84 days | $1.16 Million | $13.74K/day | $- | $- | — |